Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Argus Health
Covington
McKinsey
Express Scripts
Dow
Federal Trade Commission
Chinese Patent Office
Harvard Business School

Generated: April 27, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: lixisenatide

« Back to Dashboard

lixisenatide

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi-aventis Us ADLYXIN lixisenatide SOLUTION;SUBCUTANEOUS 208471 NDA Sanofi-Aventis U.S. LLC N 0024-5745-02
Sanofi-aventis Us ADLYXIN lixisenatide SOLUTION;SUBCUTANEOUS 208471 NDA Sanofi-Aventis U.S. LLC N 0024-5747-02
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Chinese Patent Office
Colorcon
AstraZeneca
Daiichi Sankyo
Cantor Fitzgerald
Chubb
Dow
Julphar